Exact Sciences Schedules Fourth Quarter 2023 Earnings Call
01 Février 2024 - 12:00PM
Business Wire
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of
cancer screening and diagnostic tests, today announced that the
company plans to release its fourth quarter 2023 financial results
after the close of the U.S. financial markets on February 21, 2024.
Following the release, company management will host a webcast and
conference call at 5 p.m. ET to discuss financial results and
business progress.
Fourth quarter 2023 webcast & conference call
details
Date:
Wednesday, February 21, 2024
Time:
5 p.m. ET
Webcast:
The live webcast can be accessed at
www.exactsciences.com
Telephone:
Domestic callers, dial 888-330-2384
International callers, dial +1
240-789-2701
Access code for both domestic and
international callers: 4437608
A replay of the webcast will be available at
www.exactsciences.com. The webcast, conference call, and replay are
open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests,
Exact Sciences gives patients and health care professionals the
clarity needed to take life-changing action earlier. Building on
the success of the Cologuard® and Oncotype® tests, Exact Sciences
is investing in its pipeline to develop innovative solutions for
use before, during, and after a cancer diagnosis. For more
information, visit ExactSciences.com, follow Exact Sciences on X
(formerly known as Twitter) @ExactSciences, or find Exact Sciences
on LinkedIn and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240201496564/en/
Nathan Harrill Exact Sciences Corp.
investorrelations@exactsciences.com 608-535-8659
EXACT Sciences (NASDAQ:EXAS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
EXACT Sciences (NASDAQ:EXAS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024